ALPS Advisors’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-80,025
| Closed | -$4.93M | – | 968 |
|
|
2018
Q3 | $4.93M | Buy |
80,025
+23,058
| +40% | +$1.42M | 0.03% | 164 |
|
|
2018
Q2 | $3.85M | Buy |
56,967
+6,411
| +13% | +$433K | 0.03% | 190 |
|
|
2018
Q1 | $2.74M | Buy |
50,556
+9,883
| +24% | +$536K | 0.02% | 188 |
|
|
2017
Q4 | $2.43M | Buy |
40,673
+4,883
| +14% | +$292K | 0.02% | 183 |
|
|
2017
Q3 | $1.74M | Buy |
35,790
+3,856
| +12% | +$187K | 0.01% | 200 |
|
|
2017
Q2 | $1.68M | Buy |
31,934
+3,216
| +11% | +$169K | 0.01% | 194 |
|
|
2017
Q1 | $1.3M | Sell |
28,718
-3,362
| -10% | -$152K | 0.01% | 199 |
|
|
2016
Q4 | $1.21M | Sell |
32,080
-3,478
| -10% | -$132K | 0.01% | 205 |
|
|
2016
Q3 | $1.34M | Sell |
35,558
-1,710
| -5% | -$64.5K | 0.01% | 207 |
|
|
2016
Q2 | $656K | Buy |
37,268
+7,618
| +26% | +$134K | 0.01% | 222 |
|
|
2016
Q1 | $361K | Sell |
29,650
-5,082
| -15% | -$61.9K | ﹤0.01% | 571 |
|
|
2015
Q4 | $846K | Sell |
34,732
-5,483
| -14% | -$134K | 0.01% | 222 |
|
|
2015
Q3 | $7.13K | Buy |
40,215
+15,008
| +60% | +$2.66K | 0.01% | 230 |
|
|
2015
Q2 | $445K | Buy |
25,207
+13,284
| +111% | +$235K | ﹤0.01% | 603 |
|
|
2015
Q1 | $374K | Buy |
+11,923
| New | +$374K | ﹤0.01% | 618 |
|